Metabolon Stock
Metabolon develops analytical methods and software for biomarker discovery by using metabolomics.
Sign up today and learn more about Metabolon Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Metabolon Stock
Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine. The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers to some of biology’s most difficult questions. Metabolon was founded in 2000 and headquartered in Durham, North Carolina.
Funding History
| August 2003 | $4.0M |
|---|---|
| October 2004 | $5.0M |
| January 2006 | $8.0M |
| March 2008 | $3.1M |
| October 2009 | $6.2M |
| December 2009 | $6.0M |
| August 2011 | $13.1M |
| January 2014 | $15.0M |
| March 2015 | $5.0M |
| August 2016 | $15.0M |
| August 2018 | $7.3M |
| August 2020 | $72.0M |
Management
Chief Business Officer
Rohan F. Hastie
Chief Executive Officer
Rohan F. Hastie
Board of Directors
Tom Caskey
Member of Scientific Advisory Board
Paul Schimmel
Scientific Advisory Board
Arul Chinnaiyan
Board of Directors
John Oxaal
Board of Director
Christopher W. Kersey
Chief Scientific Officer
Rangaprasad Sarangarajan
Board of Directors
Santo Costa
Interim Chief Financial Officer
John T. Kurtzweil
Board of Directors
Rudy Howard
Chief Financial Officer
Gerry Haines
Press
prnewswire - Nov, 20 2023
Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Researchen - Sep, 6 2023
Metabolon Achieves "Great Place To Work"® Certificationvcnewsdaily - Jan, 25 2023
Metabolon Secures $25Mprnewswire - Jan, 24 2023
Metabolon Secures $25 Million of Funding to Accelerate Growthwraltechwire - Aug, 11 2022
Biotech deep dive: Inside Metabolon’s biomarker testing agreement with Mayo Clinicbiospace - Jul, 25 2022
Metabolon Appoints Tom Houseman as Vice President of Operationsgenomeweb - May, 24 2022
People in the News at Pacific Biosciences, Metabolon, NeoGenomics, Morebiospace - Feb, 14 2022
Metabolon Announces Chief Financial Officer TransitionGerald M. Haines II appointed CFO effective April 1, 2022genomeweb - Feb, 11 2022
FinnGen, Metabolon to Incorporate Metabolomics in Study of Finnish Populationgenomeweb - Jan, 28 2022
In Brief This Week: Metabolon, FinnGen, BD, PerkinElmer, EureKare, Morewraltechwire - Jan, 26 2022
Newsmakers: Iqvia, Metabolon, Fathom Realty, Avaya & more company headlinesbiospace - Jan, 26 2022
Metabolon to Power Metabolomic Enriched Population Health Studies at FinnGenwraltechwire - Nov, 27 2021
‘Demystifies’ the gut: RTP biotech Metabolon unveils new metabolome platformgenomeweb - Oct, 28 2021
Metabolon Microbiome SmartPanelgenomeweb - Oct, 15 2021
Metabolon Appoints Rangaprasad Sarangarajan to Chief Scientific Officerpharmiweb - Jul, 24 2021
Metabolomics Market Few Ways You Can Apply Your Creativity Using It.genomeweb - Feb, 19 2021
Metabolon Strikes Biomarker Discovery Partnership With Cleveland Clinicwraltechwire - Sep, 24 2020
Precision health firm Metabolon raises $72M, aims to expand biomarker R&Dgenomeweb - Sep, 23 2020
Metabolon Closes $72M in Debt and Equity Fundingwraltechwire - Sep, 15 2020
Precision medicine firm Metabolon looks to raise $48M – and investors are on boardwraltechwire - Jun, 19 2020
Gut check: Triangle’s Metabolon, Canadian firm team for new means to collect sampleshubs - Jun, 5 2020
BioSpace Movers & Shakers, June 5prnewswire - Feb, 6 2018
New Metabolomic and Genomic-Informed Study Shows Use of Acetaminophen Has Unexpected Effects on Regulation of Sex Hormoneswraltechwire - Mar, 31 2017
Metabolon adds new exec, team to apply its tech to large population studieswraltechwire - Jan, 28 2017
Metabolon expands management team with CMOwraltechwire - Jan, 8 2017
Metabolon, Israeli firm team up to study chronic inflamatory diseasesstrictlyvc - Dec, 31 2016
StrictlyVC: December 6, 2016pehub - Dec, 9 2016
Essex Woodlands back Metabolonventurebeat - Dec, 8 2016
Tech to stop the diabetes tidal wavewraltechwire - Dec, 4 2016
New Raleigh healthcare startup raises nearly $3Mwraltechwire - Nov, 4 2016
CED TechVenture profile: Muses Labs, fighting Alzheimer's with 'precision medicine'venturebeat - Oct, 29 2016
Beyond Theranos: Next options for a better blood drawwraltechwire - Jul, 17 2016
Two Triangle biotechs team up to tackle Alzheimer'sbusinesswire - Jul, 13 2016
Metabolon and Muses Labs Partner to Apply Metabolomics to Alzheimer’s Diseasecbinsights - Mar, 29 2016
Big Chemical And Agribusiness Corporates: Where They’re Investing In Biotech, Ag Tech, And Foodprnewswire - Sep, 29 2015
Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025prnewswire - Sep, 29 2015
Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025businesswire - Sep, 29 2015
SCIEX Announces Game Changing LC-MS/MS Customer Solutions at ASMS Conferencebusinesswire - Sep, 29 2015
SCIEX and Metabolon® Launch the Lipidyzer™ Platform for Complete Lipid Analysis, from Sample to Biologybusinesswire - Sep, 29 2015
SCIEX and Metabolon® Launch the Lipidyzer™ Platform for Complete Lipid Analysis, from Sample to Biologybusinesswire - Sep, 29 2015
Precision BioSciences Announces Appointment of Gene Liau, Ph.D. and Bruce McCreedy, Ph.D. to Management Teambusinesswire - Sep, 29 2015
BDCA Venture Reports Q1 2015 Resultsbusinesswire - Sep, 29 2015
BDCA Venture Reports 2014 Results and Announces 2015 Quarterly Distributionsprweb - Sep, 29 2015
Global Metabolomics Market Is Expected to Reach $2,100 Million by 2019 - New Research Report by MarketsandMarketsbusinesswire - Sep, 29 2015
SCIEX Announces Game Changing LC-MS/MS Customer Solutions at ASMS Conferencefinsmes - Dec, 31 2013
FinSMEs | Metabolon Raises $15M in Series E FinancingEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
